Fundraising FoxDeinde Medical
Miramar, US · Founded 2019 · Delaware corporation
Find your way into Deinde Medical
Sign up to see every warm intro you have to Deinde Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Deinde Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BN
Bernie NavarroExecutive
PL
Prattipati LaxminarainBoard MemberLaxminarain Prattipati is an executive officer and director at Deinde Medical with background in healthcare, neurosciences, and medical devices. He has served as a board member for startups and non-profits.
ML
Marc LitzenbergExecutive
AW
Ajay WakhlooNamed on SEC filing
Board
Reported raises · per SEC filings
Form D private placements$6.5M disclosed across 4 rounds · 2019–2025
▶$185KraisedNov 2025 · 3 investors · Other Health CareRule 506(b)
▶$185KraisedNov 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bernie NavarroExecutive Officer
- Prattipati LaxminarainDirector
- Ajay WakhlooDirector
- Marc LitzenbergExecutive Officer, Director
- John McEleneyDirector
- Offering amount
- $2M
- Amount sold
- $185K
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2025 · 14 investors · Other Health CareRule 506(b)
▶$1.1MraisedFeb 2025 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John McEleneyDirector
- Bernie NavarroExecutive Officer
- Ajay WakhlooDirector
- Prattipati LaxminarainExecutive Officer, Director
- Marc LitzenbergExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.1M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedOct 2021 · 35 investors · Other Health CareRule 506(b)
▶$2.5MraisedOct 2021 · 35 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Prattipati LaxminarainExecutive Officer, Director
- Bernie NavarroExecutive Officer
- Marc LitzenbergDirector
- John McEleneyDirector
- Ajay WakhlooDirector
- Offering amount
- $2.6M
- Amount sold
- $2.5M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$2.7MraisedNov 2019 · 29 investors · Other Health CareRule 506(b)
▶$2.7MraisedNov 2019 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ajay WakhlooExecutive Officer, Director
- Marc LitzenbergExecutive Officer, Director
- Bernardo NavarroExecutive Officer
- Offering amount
- $3M
- Amount sold
- $2.7M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Deinde Medical raised?
- Deinde Medical has disclosed $6.5M raised across 4 rounds.
- Where is Deinde Medical headquartered?
- Deinde Medical is headquartered in Miramar, US.